These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 5283023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of crystalline and amorphous asparaginase in treatment of acute leukemia in children.
    Pratt CB, Verzosa M.
    Clin Pharmacol Ther; 1972; 13(3):343-8. PubMed ID: 4554659
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N, Traggis D, Das L, Kim BS, Won H, Hann L, Moloney WC, Dohlwitz A.
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow].
    Cyklis R, Armata J, Legutko L.
    Acta Haematol Pol; 1974 Apr; 5(3):201-6. PubMed ID: 4528224
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Aur RJ, Simone JV, Pratt CB.
    Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D, Cartault F, Legras B, Neimann N.
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
    Storti E, Fontana G.
    Minerva Med; 1972 Mar 31; 63(24):1445-56. PubMed ID: 4502507
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME, Ertel I, Hammond GD.
    Cancer Treat Rep; 1981 Mar 31; 65 Suppl 4():101-7. PubMed ID: 7049373
    [Abstract] [Full Text] [Related]

  • 19. [Attempts at treatment of acute leukemia with L-asparaginase].
    Lawkowicz W, Krzemińska-Lawkowiczowa, Kozlowska J, Polubiec A, Derulska D, Kolakowska-Polubiec K, Litwin J, Rokicka R.
    Acta Haematol Pol; 1971 Mar 31; 2(4):305-10. PubMed ID: 5293225
    [No Abstract] [Full Text] [Related]

  • 20. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR, Henderson E.
    Cancer; 1971 Jun 31; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.